Refine by
Blood Cell Articles & Analysis
94 news found
Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived ...
Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived ...
Obesity is a metabolic condition resulting from an imbalance between the energy consumed and the energy expended. This is often caused by an increase in the intake of calorie-dense foods and a decrease in physical activity, leading to an abnormal build-up of fat. Such fat accumulation can have serious health consequences, raising the risk of chronic diseases like cardiovascular conditions, ...
It is named lectin because it can agglutinate red blood cells (including blood group substances). Commonly used is Phytoagglutin (PNA), which is usually named after the plant from which it is extracted, such as Conconvalina (ConA), Wheat germ agglutinin (WGA), Peanut agglutinin (Peanut agglutinin, PNA) and soybean lectin (Soybean agglutinin, ...
Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes, NK cells and dendritic cells. Apheresis material is a PBMC-enriched blood product widely used in ...
MM accounts for 10% of hematological malignancies and has a current worldwide incidence level of 160,0002. This type of blood cancer forms in plasma cells (PCs) located in the bone marrow (BM). ...
About Myelofibrosis Myelofibrosis is a type of bone marrow cancer that causes extensive scarring in the bone marrow, which disrupts the body’s normal production of healthy blood cells. The result is a reduction in red blood cells, which can cause weakness and fatigue, and in platelets, which increases the risk of bleeding ...
About Myelofibrosis Myelofibrosis is a type of bone marrow cancer that causes extensive scarring in the bone marrow, which disrupts the body’s normal production of healthy blood cells. The result is a reduction in red blood cells, which can cause weakness and fatigue, and in platelets, which increases the risk of bleeding ...
Currently, patients with MDS are monitored with blood tests to measure complete blood cell counts and bone marrow analyses to detect the appearance of leukemic blasts heralding the development of AML. ...
Antibody-based systems are known to underperform for isolating Circulating Tumor Cells (CTC) due to low or lack of markers expression in critical subsets of CTC. The marker-independent ISET technology has already been shown to detect CTC from NSCLC with unparalleled sensitivity and specificity, prior to imaging. However, CTC rarity in usual blood draw volumes ...
Miller also highlighted the importance of knowing the red blood cell volume to optimize fluid management which is a key metric of Daxor’s BVA-100 blood test, which he has utilized to publish more than a dozen peer-reviewed papers in leading journals. ...
For pregnant patients who are alloimmunized with C, c, D, E, Duffy (Fya), or Kell (K) red blood cell (RBC) antibodies, this novel NIPT looks for the presence of the genetic variants that code for the corresponding fetal antigens. ...
The scars left by acne are directly related to blood heat and dampness toxin. The accumulation of blood toxins in the body, the decline in the blood’s ability to carry and supply oxygen, and the poor blood microcirculation make skin cells unable to obtain the oxygen and nutrients required for normal ...
Understanding the mechanisms by which these cells promote tumor growth and metastatic spread is critically important for the development of new treatments,” shares Yulia Nefedova, M.D., Ph.D., associate professor, Immunology, Microenvironment & Metastasis Program, Ellen and Ronald Caplan Cancer Center of The Wistar Institute. This research revealed the importance of ...
It can thermally coagulate hemoglobin in dilated capillaries and endothelial cells in capillaries within milliseconds, thereby sealing the dilated blood vessels immediately. Treatment Features 1. 980nm laser can promote collagen production, improve skin elasticity, and increase skin thickness and density. 2. 980nm laser repairs capillaries, restores the ...
SHR differs from traditional Laser/IPL it also targets the hair stem cells and blood supply that feeds it. It does not rely solely on the colour (pigment) of the hair to effectively destroy the targeted hair follicle. ...
CD Bioparticles now offers various options for researchers in Sphingomyelin, for example, the N-acetyl-D-erythro-sphingosylphosphorylcholine (Catalog: CDLP-A1144). As a major constituent of cell membranes, sphingomyelin is found at particularly high concentrations in the membranes of nerve cells (in myelin sheaths) and red blood ...
The Company’s platform includes epidemiologic, phenotypic, and genetic data that reflects a global population, as well as a biobank of patients’ blood samples and cell cultures. CENTOGENE believes this represents the only platform focused on comprehensive analysis of multi-level data to improve the understanding of rare hereditary diseases. ...
The study showed both single-vector and alternating 2-vector therapy induced robust antigen-specific T cell and antibody responses in nonhuman primates. The 2-vector approach elicited a significantly greater T cell response than single-vector therapy, and intramuscular administration showed a modest benefit over intravenous administration in both the magnitude of ...
About Hemostemix Hemostemix is a publicly traded autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company developed and has published seven peer reviewed articles about the safety and efficacy of its lead product ACP-01 as a treatment of CLI, PAD, Angina, Ischemic Cardiomyopathy, Dilated Cardiomyopathy and ...